Toward incorporating health-related quality of life as co-primary endpoints in clinical trials: time to achieve clinical important differences and quality of life profiles

16 May 2022 - Besides morbidity and mortality, quality of life is a key outcome of cancer treatments.  ...

Read more →

The EQ-HWB: overview of the development of a measure of health and wellbeing and key results

8 April 2022 - This article presents an overview of the international development of a new generic measure, the EQ Health ...

Read more →

Acceptability of manufacturer proposed utility values for NICE cancer medicine appraisals: analysis of manufacturers’ information sources

21 March 2022 - The NICE method guide for technology appraisals encourages medicine manufacturers to use the EuroQol 5 Dimension in ...

Read more →

How are child specific utility instruments used in decision making in Australia? A review of Pharmaceutical Benefits Advisory Committee public summary documents.

28 January 2022 - Measuring and valuing health-related quality of life in children can be challenging but is an important component ...

Read more →

Valuing SF-6Dv2 in Australia using an international protocol

28 September 2021 - The SF-6Dv2 is an updated version of the SF-6D, with improved consistency and dimension descriptors, and value ...

Read more →

A review of utility measurement methods used in pharmacoeconomic submissions to HIRA in South Korea: methodological consistency and areas for improvement

28 September 2021 -  This study, which was conducted as part of a project for revision of the pharmacoeconomic ...

Read more →

Assessment of FDA and EMA approved systemic oncology therapies and clinically meaningful improvements in quality of life

11 February 2021 - Are oncology therapies recently approved by the US FDA and the EMA associated with clinically meaningful improvements ...

Read more →

The estimation of health state utility values in rare diseases: overview of existing techniques

25 September 2020 - There are several techniques for estimating health state utility values, each of which presents pros and cons ...

Read more →

What is it going to be, TTO or SG? A direct test of the validity of health state valuation

12 August 2020 - It has been suggested that time trade-off yields more accurate health state valuations, because time trade-off ...

Read more →

A comparison of the EQ-5D-3L and EQ-5D-5L

12 May 2020 - Previous studies have found the EQ-5D-5L to have superior measurement properties but no study has compared ...

Read more →

Explaining health state utility assessment

17 March 2020 - Health state utilities are used to provide quantitative measures of how strongly a person values a certain ...

Read more →

Researchers wanted to study the public’s views of health-related quality of life

12 February 2020 - Applications close on Wednesday 4 March 2020 ...

Read more →

NICE to support new valuation study for England for EQ-5D-5L questionnaire

24 October 2019 - Study will measure public’s preference for different health states. ...

Read more →

The impact of moving from the EQ-5D-3L to the -5L in NICE technology appraisals

11 January 2019 - The EQ-5D instrument is NICE’s preferred measure of health-related quality of life in adults.  ...

Read more →

Evaluating progression-free survival as a surrogate outcome for health-related quality of life in oncology

1 October 2018 - Progression-free survival has become a commonly used outcome to assess the efficacy of new cancer drugs. However, ...

Read more →